Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection.
Naveed Z, Chu C, Tadrous M, Veroniki AA, Li J, Rouleau I, Febriani Y, Calzavara A, Buchan SA, Nasreen S, Schwartz KL, Wilton J, Seo CY, Thampi N, Wilson SE, Naus M, De Serres G, Janjua NZ, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network investigators. Naveed Z, et al. Among authors: naus m. Heliyon. 2024 Feb 19;10(5):e26551. doi: 10.1016/j.heliyon.2024.e26551. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38439866 Free PMC article.
A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients.
Naveed Z, Li J, Naus M, Velásquez García HA, Wilton J, Janjua NZ; Canadian Immunization Research Network Provincial Collaborative Network investigators. Naveed Z, et al. Among authors: naus m. Int J Infect Dis. 2023 Jun;131:75-78. doi: 10.1016/j.ijid.2023.03.027. Epub 2023 Mar 24. Int J Infect Dis. 2023. PMID: 36967038 Free PMC article.
Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis.
Phillips A, Jiang Y, Walsh D, Andrews N, Artama M, Clothier H, Cullen L, Deng L, Escolano S, Gentile A, Gidding G, Giglio N, Junker T, Huang W, Janjua N, Kwong J, Li J, Nasreen S, Naus M, Naveed Z, Pillsbury A, Stowe J, Vo T, Buttery J, Petousis-Harris H, Black S, Hviid A. Phillips A, et al. Among authors: naus m. Vaccine. 2023 Oct 6;41(42):6227-6238. doi: 10.1016/j.vaccine.2023.08.079. Epub 2023 Sep 5. Vaccine. 2023. PMID: 37673715 Free article.
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.
Faksova K, Walsh D, Jiang Y, Griffin J, Phillips A, Gentile A, Kwong JC, Macartney K, Naus M, Grange Z, Escolano S, Sepulveda G, Shetty A, Pillsbury A, Sullivan C, Naveed Z, Janjua NZ, Giglio N, Perälä J, Nasreen S, Gidding H, Hovi P, Vo T, Cui F, Deng L, Cullen L, Artama M, Lu H, Clothier HJ, Batty K, Paynter J, Petousis-Harris H, Buttery J, Black S, Hviid A. Faksova K, et al. Among authors: naus m. Vaccine. 2024 Apr 2;42(9):2200-2211. doi: 10.1016/j.vaccine.2024.01.100. Epub 2024 Feb 12. Vaccine. 2024. PMID: 38350768 Free article.
mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network.
Soe P, Wong H, Naus M, Muller MP, Vanderkooi OG, Kellner JD, Top KA, Sadarangani M, Isenor JE, Marty K, De Serres G, Valiquette L, McGeer A, Bettinger JA; Canadian Immunization Research Network. Soe P, et al. Among authors: naus m. Vaccine. 2024 May 6:S0264-410X(24)00535-8. doi: 10.1016/j.vaccine.2024.04.096. Online ahead of print. Vaccine. 2024. PMID: 38714447 Free article.
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study.
Muller MP, Navarro C, Wilson SE, Shulha HP, Naus M, Lim G, Padhi S, McGeer A, Finkelstein M, Liddy A, Bettinger JA; for CANVAS. Muller MP, et al. Among authors: naus m. Vaccine. 2024 Jan 25;42(3):535-540. doi: 10.1016/j.vaccine.2023.12.068. Epub 2024 Jan 9. Vaccine. 2024. PMID: 38199921 Free article.
Uptake of Mpox vaccination among transgender people and gay, bisexual and other men who have sex with men among sexually-transmitted infection clinic clients in Vancouver, British Columbia.
Gilbert M, Ablona A, Chang HJ, Grennan T, Irvine MA, Sarai Racey C, Salway T, Naus M, Dawar M, Ogilvie G. Gilbert M, et al. Among authors: naus m. Vaccine. 2023 Apr 6;41(15):2485-2494. doi: 10.1016/j.vaccine.2023.02.075. Epub 2023 Mar 7. Vaccine. 2023. PMID: 36894397 Free PMC article.
Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines.
Naveed Z, Li J, Wilton J, Spencer M, Naus M, Velásquez García HA, Kwong JC, Rose C, Otterstatter M, Janjua NZ; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Naveed Z, et al. Among authors: naus m. J Am Coll Cardiol. 2022 Nov 15;80(20):1900-1908. doi: 10.1016/j.jacc.2022.08.799. J Am Coll Cardiol. 2022. PMID: 36357091 Free PMC article.
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.
Skowronski DM, Febriani Y, Ouakki M, Setayeshgar S, El Adam S, Zou M, Talbot D, Prystajecky N, Tyson JR, Gilca R, Brousseau N, Deceuninck G, Galanis E, Fjell CD, Sbihi H, Fortin E, Barkati S, Sauvageau C, Naus M, Patrick DM, Henry B, Hoang LMN, De Wals P, Garenc C, Carignan A, Drolet M, Jassem AN, Sadarangani M, Brisson M, Krajden M, De Serres G. Skowronski DM, et al. Among authors: naus m. Clin Infect Dis. 2022 Nov 30;75(11):1980-1992. doi: 10.1093/cid/ciac290. Clin Infect Dis. 2022. PMID: 35438175 Free PMC article.
121 results